Transcatheter Heart Valves Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
Transcatheter Heart Valves Pipeline Products Market Report Overview
Transcatheter heart valves are synthetic valves made from biological tissues surrounded by a steel, cobalt-chromium, or nitinol stent. These valves can be either balloon expandable or self-expandable. The Transcatheter Heart Valves pipeline market research report provides comprehensive information about the Transcatheter Heart Valves pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Transcatheter Heart Valves Pipeline Products Market Segments
The key segments in the Transcatheter Heart Valves Pipeline Products market are Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral Valve Repair (TMVR), and Transcatheter Mitral Valve Implantation (TMVI). As of February 2023, Transcatheter Aortic Valve Replacement (TAVR) dominated the market.
Transcatheter Heart Valves Pipeline Products Market Analysis by Segments, 2023 (%)
For more segments insights into the Transcatheter Heart Valves pipeline products market, download a free report sample
Transcatheter Heart Valves Pipeline Products Market Segmentation by Territories
Some of the key territories with products in the pipeline are the US, China, Europe, Canada, Israel, Taiwan, Japan, Hong Kong, Macau, and Australia among others. As of February 2023, the US has the highest number of products in the pipeline out of them all.
Transcatheter Heart Valves Pipeline Products Market Analysis, by Territories, 2023 (%)
For more territory insights into the Transcatheter Heart Valves pipeline products market, download a free report sample
Transcatheter Heart Valves Pipeline Products Market Segmentation by Regulatory Paths
The key regulatory paths followed by the Transcatheter Heart Valves pipeline products market are PMA, NMPA, CE, MDL, BOPA, MDCO, Shonin, TGA, ICAC, and 510(k). Most of the products follow the PMA pathway to enter the market.
Transcatheter Heart Valves Pipeline Products Market Analysis, by Regulatory Paths, 2023 (%)
For more Transcatheter Heart Valves pipeline products regulatory path insights, download a free report sample
Transcatheter Heart Valves Pipeline Products Market - Competitive Landscape
Some of the leading companies in the Transcatheter Heart Valves pipeline products market are 3DT Holdings LLC, 4C Medical Technologies Inc, Abbott Vascular Inc, Aegis Surgical Limited, Affluent Medical SASU, Anchorvalve, Annulon, Anteris Technologies Ltd, AorTx, Inc., and Arbor Surgical Technologies, Inc.
3DT Holdings LLC (3DT): Headquartered in Indiana, USA, 3DT is a contract research organization that offers drug development and manufacturing services. It develops, manufactures, and markets drugs for the treatment of cardiovascular, metabolic disorders, diabetes, and vascular diseases.
4C Medical: 4C Medical is a medical device company developing minimally invasive therapies for structural heart disease, focusing initially on mitral regurgitation (MR) therapy and subsequently on tricuspid regurgitation therapy. The company’s implant is the first MR therapy with supra-annular positioning and atrial-only fixation.
Abbott Vascular Inc: Headquartered in California, USA, Abbott Vascular develops, manufactures, and markets cardiovascular devices. The company offers coronary intervention, peripheral intervention, and structural heart products. The company provides minimally invasive treatment for mitral regurgitation and other structural defects of the heart. It also offers education and training services for healthcare professionals.
Transcatheter Heart Valves Pipeline Products Market Report Overview
| Key Segments | Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral Valve Repair (TMVR), and Transcatheter Mitral Valve Implantation (TMVI) |
| Key Territories | The US, China, Europe, Canada, Israel, Taiwan, Japan, Hong Kong, Macau, and Australia |
| Key Regulatory Paths | PMA, NMPA, CE, MDL, BOPA, MDCO, Shonin, TGA, ICAC, and 510(k) |
| Leading Companies | 3DT Holdings LLC, 4C Medical Technologies Inc, Abbott Vascular Inc, Aegis Surgical Limited, Affluent Medical SASU, Anchorvalve, Annulon, Anteris Technologies Ltd, AorTx, Inc., and Arbor Surgical Technologies, Inc |
Scope
This report provides:
- Extensive coverage of the transcatheter heart valves under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details, and other developmental activities
- The report reviews the major players involved in the development of transcatheter heart valves and lists all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment/industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage
- Identify and understand important and diverse types of Transcatheter Heart Valves under development
- Develop market-entry and market-expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory, and estimated launch date
4C Medical Technologies Inc
Abbott Vascular Inc
Aegis Surgical Limited
Affluent Medical SASU
Anchorvalve
Annulon
Anteris Technologies Ltd
AorTx, Inc.
Arbor Surgical Technologies, Inc.
Atlas Medical
AVVie GmbH
Biotronik AG
Boston Children's Hospital
Boston Scientific Corp
Cardiac Dimensions Inc
CardioMech AS
Cardiovalve Ltd
Carena Healthcare Ltd
Cephea Valve Technologies, Inc.
Chengdu Silara Meditech Inc
Colibri Heart Valve LLC
ContiTech (Beijing) Medical Technology Co Ltd
coramaze technologies GmbH
Daidalos Solutions BV
Direct Flow Medical Inc (Inactive)
DSM Dyneema BV
Dura LLC
Edwards Lifesciences Corp
Emory University
Endoluminal Technology Research LLC
Endomimetics LLC
Enlight Medical Technologies (Shanghai) Co Ltd
Florida International University
Folda LLC
Foldax Inc
Half Moon Medical Inc
Hangzhou DeJin Medtech Co Ltd
Hangzhou Valgen Medtech Co Ltd
Hangzhou Valued Medtech Co Ltd
HighLife SAS
HLT, Inc.
InnovHeart SRL
JC Medical, Inc.
JenaValve Technology GmbH
Jenscare Scientific Co Ltd
Jiangsu Zhenyi Medical Technology Co Ltd
Jinshi Biotechnology (Changshu) Co Ltd
Kekai Life Sciences
KOKA Lifesciences Co Ltd
LaPlace Interventional Inc
Lepu Medical Technology (Beijing) Co Ltd
LivaNova PLC
Mayo Clinic
Medfree Inc
Medtentia International Ltd Oy
Medtronic Plc
Meril Life Sciences Pvt Ltd
Micro Interventional Devices, Inc.
MicroPort CardioFlow Medtech Corp
MicroPort MedBot (Shanghai) Co Ltd
MicroPort Scientific Corp
Mitral Heal
Mitralix Ltd.
MitrAssist Ltd.
Mitria Medical LLC
MValve Technologies Ltd.
Nanjing Shengde Medical Technology Co Ltd
NaviGate Cardiac Structures, Inc.
Neochord Inc
Neovasc Inc
NewMed Medical Co Ltd
North Carolina State University
Novogate Medical Ltd.
NVT AG
Nyra Medical Inc
Open Stent Solution
Opsens Inc
OrbusNeich P&F
P+F Products + Features GmbH
Peca Labs Inc
Peijia Medical Ltd
Pi-Cardia Ltd
Pipeline Medical Technologies Inc
Polares Medical SA
PolyNova Cardiovascular Inc
Polyvascular Corp
RegenaGraft
ReValve Med Inc
RUA Life Sciences Plc
SAS Cormove
Shanghai Hanyu Medical Technology Co Ltd
Shanghai Healing Medical Instruments Co Ltd
Shanghai Huihe Medical Technology Co Ltd
Shanghai Shenqi Medical Technology Co Ltd
Sino Medical Sciences Technology Inc
St. Jude Medical LLC
Stony Brook University
Strait Access Technologies (Pty) Ltd
Sutra Medical Inc
Symetis SA
The University of British Columbia
Thubrikar Aortic Valve, Inc.
Tioga Medical Inc
Trinity College Dublin
Trisol Medical Ltd
University College London
University of California
University of California San Francisco
University of Cambridge
University of Iowa
University of Pennsylvania
Valcare Medical
VALFIX Medical Ltd
Valtech Cardio Ltd
Vascudyne Inc
Vascular Concepts Ltd
Vascular Innovations Co Ltd
Venus Medtech Hangzhou Inc
Venus MedTech of America
Vesalius Cardiovascular Inc
Vvital Biomed Ltd
Xeltis AG
Youngheartvalve LLC
Table of Contents
Frequently asked questions
-
What are the key segments in the Transcatheter Heart Valves Pipeline Products market?
The key segments in the Transcatheter Heart Valves Pipeline Products market are Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral Valve Repair (TMVR), and Transcatheter Mitral Valve Implantation (TMVI).
-
What are the key territories in the Transcatheter Heart Valves pipeline products market?
The US, China, Europe, Canada, Israel, Taiwan, Japan, Hong Kong, Macau, and Australia are some of the key territories with products in the pipeline.
-
What are the key regulatory paths of the Transcatheter Heart Valves pipeline products market?
Some of the key regulatory paths followed by the Transcatheter Heart Valves pipeline products market are PMA, NMPA, CE, MDL, BOPA, MDCO, Shonin, TGA, ICAC, and 510(k).
-
What are the leading companies in the Transcatheter Heart Valves pipeline products market?
Some of the leading companies in the Transcatheter Heart Valves pipeline products market are 3DT Holdings LLC, 4C Medical Technologies Inc, Abbott Vascular Inc, Aegis Surgical Limited, Affluent Medical SASU, Anchorvalve, Annulon, Anteris Technologies Ltd, AorTx, Inc., and Arbor Surgical Technologies, Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Sample Report
Transcatheter Heart Valves Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:
- Assess the relevance of the report
- Evaluate the quality of the report
- Justify the cost
Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.
